Abstract
BackgroundClaudin18.2 (CLDN18.2) is a tight junction protein that has been identified as a clinically proven target in gastric cancer. Stimulation of 4-1BB with agonistic antibodies is also a promising strategy...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have